Related Articles
Vascular endothelial growth factor expression and T-regulatory cells in premenopausal breast cancer
Survival outcome of combined GnRH agonist and tamoxifen is comparable to that of sequential adriamycin and cyclophosphamide chemotherapy plus tamoxifen in premenopausal patients with early breast cancer
LH-RH analogues in the treatment of young women with early breast cancer: Long-term follow-up of a phase II study
Combined effects of lutenizing hormone-releasing hormone analogue with antiestrogen on rat mammary tumors
High-risk early breast cancer in patients under 40 years of age: Improved clinical outcome with total estrogen blockade and tailored chemotherapy